Sobre 2 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Explore the complete record of transactions filed by Neupert Peter M, Consejero. Officer active across 4 companies, notably Adaptive Biotechnologies Corp. Cumulatively, 22 disclosures have been recorded. Breakdown: 3 buys · 3 sells. Total volume traded: €3.4m. History available since 26 January 2022. The latest transaction was disclosed on 17 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Neupert Peter M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
NEUPERT PETER M is Administrateur and has filed 18 disclosures in total. In the 18 sampled filings, there were only purchases, for a total of EUR 731417, mainly through option exercises, between 2022-01-28 and 2026-03-06, in relation to Laboratory CORP of America Holdings, Fortrea Holdings Inc. and Adaptive Biotechnologies Corp.